tat Gene Products, Human Immunodeficiency Virus
"tat Gene Products, Human Immunodeficiency Virus" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Proteins encoded by the TAT GENES of the HUMAN IMMUNODEFICIENCY VIRUS.
MeSH Number(s)
D12.776.260.755.199.500
D12.776.930.900.199.500
D12.776.964.775.562.773
D12.776.964.925.984.400.500
Concept/Terms
tat Gene Products, Human Immunodeficiency Virus- tat Gene Products, Human Immunodeficiency Virus
- HIV Transacting Transcription Protein
- Trans-Acting Transcription Factor, HIV
- Trans Acting Transcription Factor, HIV
- HIV tat Protein
- tat Protein, HIV
Below are MeSH descriptors whose meaning is more general than "tat Gene Products, Human Immunodeficiency Virus".
Below are MeSH descriptors whose meaning is more specific than "tat Gene Products, Human Immunodeficiency Virus".
This graph shows the total number of publications written about "tat Gene Products, Human Immunodeficiency Virus" by people in Harvard Catalyst Profiles by year, and whether "tat Gene Products, Human Immunodeficiency Virus" was a major or minor topic of these publication.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 0 | 1 | 1 |
| 1994 | 0 | 1 | 1 |
| 1995 | 0 | 3 | 3 |
| 1996 | 0 | 2 | 2 |
| 1997 | 0 | 5 | 5 |
| 1998 | 0 | 5 | 5 |
| 1999 | 0 | 4 | 4 |
| 2000 | 0 | 5 | 5 |
| 2001 | 0 | 8 | 8 |
| 2002 | 0 | 5 | 5 |
| 2003 | 0 | 2 | 2 |
| 2004 | 0 | 2 | 2 |
| 2005 | 0 | 2 | 2 |
| 2006 | 0 | 4 | 4 |
| 2007 | 1 | 1 | 2 |
| 2008 | 2 | 0 | 2 |
| 2009 | 0 | 1 | 1 |
| 2010 | 1 | 1 | 2 |
| 2011 | 2 | 3 | 5 |
| 2012 | 3 | 2 | 5 |
| 2013 | 1 | 1 | 2 |
| 2014 | 3 | 2 | 5 |
| 2015 | 2 | 1 | 3 |
| 2016 | 1 | 1 | 2 |
| 2017 | 1 | 0 | 1 |
| 2019 | 1 | 0 | 1 |
| 2020 | 0 | 2 | 2 |
| 2021 | 1 | 3 | 4 |
| 2022 | 1 | 2 | 3 |
| 2023 | 0 | 1 | 1 |
Below are the most recent publications written about "tat Gene Products, Human Immunodeficiency Virus" by people in Profiles.
-
Genetic variation of the HIV-1 subtype C transmitted/founder viruses long terminal repeat elements and the impact on transcription activation potential and clinical disease outcomes. PLoS Pathog. 2023 Jun; 19(6):e1011194.
-
The chaperone protein p32 stabilizes HIV-1 Tat and strengthens the p-TEFb/RNAPII/TAR complex promoting HIV transcription elongation. Proc Natl Acad Sci U S A. 2023 01 03; 120(1):e2217476120.
-
Age-related neuroendocrine, cognitive, and behavioral co-morbidities are promoted by HIV-1 Tat expression in male mice. Aging (Albany NY). 2022 07 12; 14(13):5345-5365.
-
HIV-Tat protein-accelerated aging. Aging (Albany NY). 2022 05 27; 14(11):4618-4619.
-
Stochastic pausing at latent HIV-1 promoters generates transcriptional bursting. Nat Commun. 2021 07 23; 12(1):4503.
-
In vivo proton magnetic resonance spectroscopy detection of metabolite abnormalities in aged Tat-transgenic mouse brain. Geroscience. 2021 08; 43(4):1851-1862.
-
Exploring novel and potent cell penetrating peptides in the proteome of SARS-COV-2 using bioinformatics approaches. PLoS One. 2021; 16(2):e0247396.
-
Inhibition of HIV-1 gene transcription by KAP1 in myeloid lineage. Sci Rep. 2021 01 29; 11(1):2692.
-
Multiplexed tat-Targeting CRISPR-Cas9 Protects T Cells from Acute HIV-1 Infection with Inhibition of Viral Escape. Viruses. 2020 10 28; 12(11).
-
HIV-1 Tat promotes age-related cognitive, anxiety-like, and antinociceptive impairments in female mice that are moderated by aging and endocrine status. Geroscience. 2021 02; 43(1):309-327.